Cogent Biosciences COGT Insider Ownership

NASDAQ COGT
$34.83 -0.12 (-0.34%)
As of: Sep 4, 2026 · 11:49 AM EDT

Insider Holdings by Owner

1.39Mn Shares

Insider Ownership Statistics

as of 30 Jun, 2025
Insider Ownership
2.31%
-0.024% pp QoQ
Shares Held by Insiders
2.65Mn
filed for Jun 2025
0.00% QoQ
Shares Outstanding
128.90Mn
128,899,408 shares
Direct Holdings
0
Indirect: 2.65Mn
Net Shares Traded (QoQ)
0
no net change in Jun 2025
Insiders Holding Shares
6
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest
Average ownership
Peak ownership

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter
Net over range
Buying quarters

Insider Ownership Summary

Quarter ending 30 Jun, 2025

As of August 29, 2026, the three largest insider holders of COGT are Andrew R Robbins (President And Ceo, 657.50K shares), Andrew R Robbins (President And Ceo, 657.50K shares), Cole Pinnow (Chief Commercial Officer, 216.65K shares).

Form 4 Holdings

Insiders Holding COGT

Insiders 6
Shares held 1.39Mn
Of outstanding 1.08%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Andrew R Robbins President And Ceo 497,503 160,000 657,503 47.3% 21 May, 2026
2 Cole Pinnow Chief Commercial Officer 216,650 0 216,650 15.6% 19 Dec, 2025
3 John Edward Robinson Chief Scientific Officer 140,002 0 140,002 10.1% 30 Dec, 2025
4 Jessica Sachs Chief Medical Officer 133,938 0 133,938 9.6% 30 Dec, 2025
5 John L. Green Chief Financial Officer 131,834 0 131,834 9.5% 30 Dec, 2025
6 Evan Kearns Chief Legal Officer 109,398 0 109,398 7.9% 30 Dec, 2025

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

505 Insider Transactions

Source SEC Form 4
Latest quarter Jun 2025
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
27 Aug, 2026 Arlene Morris Director Acquired M 41,927 $5.64 $236.47K 41,927 Direct
27 Aug, 2026 Arlene Morris Director Acquired M 3,583 $2.52 $9.03K 45,510 Direct
27 Aug, 2026 Arlene Morris Director Disposed S 42,349 $37.09 $1.57Mn 3,161 Direct
27 Aug, 2026 Arlene Morris Director Disposed S 3,161 $37.54 $118.66K 0 Direct
27 Aug, 2026 Arlene Morris Director Disposed M 41,927 $0.00 $0 2,773 Direct
27 Aug, 2026 Arlene Morris Director Disposed M 3,583 $0.00 $0 0 Direct
01 Jul, 2026 Karen Jean Ferrante Director Acquired A 627 $0.00 $0 627 Direct
09 Jun, 2026 Todd Shegog Director Acquired A 17,901 $0.00 $0 17,901 Direct
09 Jun, 2026 Karen Jean Ferrante Director Acquired A 17,901 $0.00 $0 17,901 Direct
09 Jun, 2026 Matthew Ros Director Acquired A 17,901 $0.00 $0 17,901 Direct
09 Jun, 2026 Christopher W. Cain Director Acquired A 17,901 $0.00 $0 17,901 Direct
09 Jun, 2026 Todd Shegog Director Acquired A 17,901 $0.00 $0 17,901 Direct
09 Jun, 2026 Peter Evan Harwin Director Acquired A 17,901 $0.00 $0 17,901 Direct
09 Jun, 2026 Arlene Morris Director Acquired A 17,901 $0.00 $0 17,901 Direct
19 May, 2026 Andrew R Robbins President And Ceo Disposed G 160,000 $0.00 $0 497,503 Direct
19 May, 2026 Andrew R Robbins President And Ceo Disposed G 160,000 $0.00 $0 497,503 Direct
19 May, 2026 Andrew R Robbins President And Ceo Acquired G 160,000 $0.00 $0 160,000 Indirect
19 May, 2026 Andrew R Robbins President And Ceo Acquired G 160,000 $0.00 $0 160,000 Indirect
01 Apr, 2026 Karen Jean Ferrante Director Acquired A 686 $0.00 $0 686 Direct
01 Jan, 2026 Karen Jean Ferrante Director Acquired A 643 $0.00 $0 643 Direct